fbpx Skip to main content

FRIDAY, Sept. 18, 2020 (HealthDay News) — Depression is common among patients with psoriasis, according to a study published online Sept. 14 in Dermatology.

Albert Duvetorp, from Skåne University Hospital in Malmö, Sweden, and colleagues used data from the Swedish Prescribed Drug Register and electronic medical records (April 9, 2008, to Jan. 1, 2016) to assess the prevalence of pharmacologically treated depression among individuals with and without psoriasis in a Swedish population using International Classification of Diseases, Tenth Revision codes.

The researchers found that the risk for pharmacologically treated depression was higher in individuals with psoriasis (age- and sex-adjusted odds ratio, 1.55), with 21.1 percent of women with psoriasis receiving pharmacological treatment for depression compared with 14.2 percent of the control population. Compared with men with psoriasis, the prevalence of depression was significantly higher in women with psoriasis. Male and female patients with psoriasis younger than 31 years had the highest risk for suffering from depression.

“The results of the current study underline the need for dermatologists to adopt a holistic approach, looking beyond the skin, when handling patients with psoriasis in everyday clinical practice,” the authors write.

Abstract/Full Text

You May Also Like::  Q & A with Dr. JiaDe Yu on Atopic Dermatitis

“Keeping up with the indications and adverse reactions to immune checkpoint inhibitors can be a full-time job. Cutaneous side effects occur in up to 45% of patients treated with ipilimumab and 34% of patients treated with nivolumab and pembrolizumab.” https://bit.ly/3FGtxtd

.@spfnomt: This month’s #DermWorld article “Estate planning 101” is especially important for young physicians to read. The long, all-consuming years between adolescence and physicianhood can become a blur...https://bit.ly/3FxOtCv

That’s a wrap #AAD2023! 5 days of soaking up knowledge from dermatologists on topics such as hidradenitis, melasma, & dietary triggers of common dermatoses.

I LOVED the #womenshealth focused sessions on vulvar dermatoses and pregnancy medication safety.


New approach uses microbiome to treat skin disease by repairing the injured microbiome that allowed inflammation to flare up in the first place, rather than reducing the inflammation after the fact. https://bit.ly/3Jt6H9v

Load More